Maizel Ari bought AXSM
April 21, 2026 · Form 4 insider transaction
Maizel Ari bought 7,224 shares of Axsome Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
7,224
Price
$0.00
Total value
N/A
InsiderMaizel Ari
RoleOfficer
SecurityPerformance Stock Units
Transaction codeA: Grant or award
Transaction dateApril 21, 2026
Filing dateApril 23, 2026
Shares owned after7,224
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each performance stock unit ("PSU") represents a contingent right to receive one share of the Issuer's common stock.; Each PSU will vest upon achievement of certain sales and commercial launch milestones, subject to the reporting person's continued service as of each vesting date.